Pediatric Dosing

• 21 CFR 201.57(f)(9)(iv)

• Allows inclusion of pediatric use information in the label without controlled clinical trials of the use in children.

• Course of disease should be similar in pediatric and adult populations.

• Sponsor must provide other information to support use in children.

Previous slide

Next slide

Back to first slide

View graphic version